Clinical Trials Logo

Muscle Weakness clinical trials

View clinical trials related to Muscle Weakness.

Filter by:

NCT ID: NCT03863080 Completed - Myasthenia Gravis Clinical Trials

A Study of RVT-1401 in Myasthenia Gravis (MG) Patients

Start date: May 21, 2019
Phase: Phase 2
Study type: Interventional

The purpose of the current study is to assess safety/tolerability and key pharmacodynamic (PD) effects that are considered to be associated with clinical benefit (reduction of total IgG and anti-AChR-IgG) in Myasthenia Gravis patients following treatment with RVT-1401 (also known as IMVT-1401) compared to placebo.

NCT ID: NCT03850106 Completed - Weakness, Muscle Clinical Trials

Effects of INDUS810 on Body Composition, Muscular Performance, and Training Adaptations

Start date: July 11, 2018
Phase: N/A
Study type: Interventional

The purpose of this 12-week, interventional study is to determine the effects of oral supplementation with Indus810 (dietary supplement with active ingredient Fenugreek) on body composition, muscular performance, and training adaptations

NCT ID: NCT03819959 Completed - Critical Illness Clinical Trials

Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma

MIRACLE II
Start date: March 24, 2019
Phase:
Study type: Observational

In this mono-center pilot trial, polytrauma patients admitted to intensive care will be included. Investigators are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.

NCT ID: NCT03818152 Completed - Cerebral Palsy Clinical Trials

Reliability and Validity of Strength Measurements of the Lower Limbs in Children With Bilateral Spastic Cerebral Palsy.

Start date: November 30, 2018
Phase: N/A
Study type: Interventional

Specific musculo-tendinous adaptations in children with cerebral palsy (CP) have an influence on muscle strength and consequently on functional behavior and participation. Evidence of strength training programs has been shown on level of body function but transfer to levels of activity and participation is still limited. Lack of transfer is related to lack of specificity of the training and poor overall quality of the interventions (intensity, duration, frequency and/or type). The use of functional strength exercises to assess and train strength of the lower limbs in children with CP is well implemented in the most functional children with CP (GMFCS-level I). To assess isometric strength the hand held dynamometer (HHD) can be used in clinical settings but reliability of this tool is questionable. The aim of this study is to adapt existing functional strength tests for less functional children with CP (focussing on GMFCS level II and III) and to investigate the correlation with isometric strength measurements and other functional parameters.

NCT ID: NCT03817086 Completed - Clinical trials for Traumatic Brain Injury

Physical and Mental Practice for Bimanual Coordination Rehabilitation

Start date: June 28, 2017
Phase: N/A
Study type: Interventional

Traumatic Brain Injury (TBI)patients often suffer from loss of muscle strength in the hand and foot, decrease in coordination and high muscle tone (spasticity). In this study, investigators seek to compare how two different training programs can improve the coordination and symptoms of fatigue in individuals with movement deficits secondary to TBI. Using brain imaging, the study will also investigate changes in brain structure and activity associated with hand movement.

NCT ID: NCT03789175 Completed - Cancer Clinical Trials

Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

Start date: March 25, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Background: Nicotinamide riboside (NR) is a vitamin B3 dietary supplement. It may help improve muscle function, that may in turn may improve a person s exercise capacity. Researchers want to study how skeletal muscle responds to NR in an individual who has Li-Fraumeni Syndrome and slow muscle energy recovery after exercise. Objective: To study how nicotinamide riboside affects skeletal muscle after exercise. Eligibility: One person at least 18 years old with Li-Fraumeni syndrome and a certain gene mutation Design: The participant will be screened with a medical history, physical exam, and blood and urine tests. The participant may also have a heart test. The participant will maintain their regular diet and supplements during the study. The participant will take the study drug as 1-4 tablets twice a day for 12 weeks. The participant may be contacted with reminders and questions about side effects. The participant will have 4-5 visits over 18-30 weeks. At visits, the participant will repeat screening tests. At some visits they will also have: - Ultrasound of the heart with a wand placed on the chest. - Test of oxygen used at rest and exercise, while wearing a face mask. - Exercise test on a treadmill or bicycle with electrodes on the skin. - Magnetic resonance spectroscopy. The participant will have no caffeine for 12 hours. Then they will lie in a machine for about 2 hours. Sometimes they will lie still. Sometimes they will be asked to move. Health questionnaire The participant may have a skin sample taken by needle. The participant will be withdrawn from the study if they become pregnant.

NCT ID: NCT03788577 Completed - Quality of Life Clinical Trials

Impact of Oligonol to Cardiometabolic Risk and Muscular Health

Start date: December 4, 2018
Phase: N/A
Study type: Interventional

This project will mainly focus on Middle and old-aged adults, and examine whether Cardiovascular and metabolic risks can be reduced. In the meanwhile, this project will develop strategies for improving muscle loss , muscle strength decline, and the quality life of the elderly.

NCT ID: NCT03784456 Completed - Muscle Weakness Clinical Trials

Impact of Increased Protein Density Diet to Muscle Mass and Strength Among Mid-aged and Older Adults

Start date: February 13, 2019
Phase: N/A
Study type: Interventional

The subjects of this intervention program are mainly based on community-dwelling mid-aged and older adults. The investigator's program will provide meals containing different proportionated protein.As this project is a double blind test, only the investigators will know which subject corresponding to specific group of diets. Besides, the investigators use the valued-based healthcare standard set as well as the Center for Epidemiological Studies-Depression, Charlson's comorbidity index Montreal Cognitive Assesment ,and Mini Nutritional Assessment as outcome measures and to use the randomized controlled trial design to validate if increased protein density diet could improve the vitality and health of mid-aged and old adults .

NCT ID: NCT03772587 Completed - Clinical trials for Generalized Myasthenia Gravis

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

Start date: April 10, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and efficacy of M281 administered to participants with generalized myasthenia gravis (gMG) who have an insufficient clinical response to ongoing standard of care therapy.

NCT ID: NCT03770442 Completed - Muscle Weakness Clinical Trials

Muscle Wasting in the Critically Ill

Start date: January 14, 2019
Phase: N/A
Study type: Interventional

Muscle wasting is a common consequence of critical illness, and has a profound impact upon the rehabilitation of those who survive admission to critical to care. The investigators intend to assess if the application of 10 sessions over two weeks of passive cycling with electrical stimulation to the lower limbs and abdomen can prevent muscle loss, or at least cause less muscle loss, compared to patients who receive standard daily sessions of physiotherapy. This will be done by comparing the changes in muscle size on ultrasound between the two groups, comparing functional measures at a 3 month follow up, and by performing translational research using tissue samples taken during the study.